“Junk” genome may actually unlock future cancer treatment
Dominique Verhelle, co-founder and CEO of NextRNA Therapeutics, which is working on multiple lncRNAs … [+] associated with multiple cancers where there is a significant unmet need. Dominique Verhelle In 2016, Belgian cancer biologist Eleonora Leucci published the first of several papers on a particular RNA molecule called SAMMSON, which was particularly active in melanoma … Read more